CDC-RFA-PS25-0008 medical monitoring project

The Centers for Disease Control and Prevention awarded a $1,543,878 cooperative agreement to the Indiana Department of Health on September 30, 2025, under the HIV/AIDS Surveillance program (CFDA 93.944) to operate the Indiana Medical Monitoring Project, a supplemental HIV/AIDS surveillance system running through September 29, 2030.

The Indiana MMP will collect clinical and behavioral data from a probability sample of 400 HIV-infected persons receiving and non-receiving care in Indiana, selected by CDC from a sampling frame developed by the state from the Enhanced HIV/AIDS Reporting System. Indiana will administer standardized interviews and medical record abstraction using instruments developed by CDC to characterize clinical status, HIV-related comorbidities, care and support service access and quality, ongoing transmission risk behaviors, prevention service utilization, and met and unmet needs for HIV care and prevention services. The project will measure the impact of HIV treatments on morbidity and mortality, assess quality of life and antiretroviral therapy adherence among persons living with HIV, track changing epidemic trends, and generate data to evaluate and direct future HIV surveillance, prevention, and services activities across Indiana.

Performance occurs in Indiana. The award obligates $1,543,878 for the period September 30, 2025, through September 29, 2030.